Literature DB >> 14774366

Evaluation of oral, intravenous, and intramuscular aureomycin and the correlation between the in vivo and in vitro activity.

M KLEIN, S E SCHORR, S TASHMAN, A D HUNT.   

Abstract

Entities:  

Keywords:  AUREOMYCIN

Mesh：

Substances：

Year:  1950        PMID： 14774366      PMCID： PMC385858          DOI： 10.1128/jb.60.2.159-169.1950

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  3 in total

1.  FURTHER EXPERIENCES WITH INTRAVENOUS AUREOMYCIN THERAPY. A STUDY OF 116 CASES.

Authors:  M Sanders; J M Rumball; C Solomon; M G Soret; N I Ricci
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

2.  Intravenous administration of aureomycin including studies on the concentration in the serum.

Authors:  R V RANDALL; R W TAYLOR; W E WELLMAN
Journal:  Proc Staff Meet Mayo Clin       Date:  1949-12-07

3.  Aureomycin treatment of pneumococcic pneumonia; clinical and laboratory studies on 33 patients.

Authors:  T M GOCKE; H S COLLINS; M FINLAND
Journal:  Arch Intern Med (Chic)       Date:  1949-12
  3 in total
  2 in total

1.  The action of aureomycin in pneumococcal infections in normal and leucopenic rabbits and in mice.

Authors:  J BOWDEN
Journal:  Br J Exp Pathol       Date:  1953-10

2.  Some biological properties of cephalosporin P1.

Authors:  A C RITCHIE; N SMITH; H W FLOREY
Journal:  Br J Pharmacol Chemother       Date:  1951-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.